Oncogenic IRFs provide a survival advantage for Epstein-Barr virus- or human T-cell leukemia virus type 1-transformed cells through induction of BIC expression.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples